Fairfield Financial Advisors’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-54
Closed -$1.73K 337
2022
Q4
$1.73K Hold
54
﹤0.01% 278
2022
Q3
$2.25K Hold
54
﹤0.01% 285
2022
Q2
$2.27K Hold
54
﹤0.01% 269
2022
Q1
$3.64K Buy
+54
New +$3.64K ﹤0.01% 270